Insider buying
~$1.22M50K sh @ $24.42
Traded Nov 9 · filed 3 days later
A major shareholder of Claritev paid $1.22M out of pocket for Claritev shares. 1 other person at Claritev bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 11, 2026 · Filed Nov 13, 2026
The CEO of Claritev paid $150K out of pocket for Claritev shares. 1 other person at Claritev bought some too, in the same month. It was the first purchase in 15 months.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$149,927
Shares × reported transaction price
$100K–$500K
+9.8%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 15 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 4 earlier confirmed purchases
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 1.5% of the CEO's reported total pay for fiscal 2025 ($10.2M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-03-20. The proxy names this person as CEO for that year. A size comparison, not a judgement
96 days after results of Aug 7, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $28.21 on Nov 11, 2026, 109% above its 52-week low and 52% below its high, after a 33% rise over the previous 30 trading days
52-week range $13.47 (Feb 27, 2026) to $58.62 (Nov 12, 2025), 33% of the way up, from 250 adjusted closes. 30 trading days earlier: $21.17 on Sep 30, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Bought 96 days after CTEV's last results announcement; 87% of its insiders' purchases since 2020 were made within 30 days after one
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider buying
Traded Nov 9 · filed 3 days later
A major shareholder of Claritev paid $1.22M out of pocket for Claritev shares. 1 other person at Claritev bought some too, in the same month.
Insider buying
Traded Nov 10 · filed 2 days later
A major shareholder of Claritev paid $1.71M out of pocket for Claritev shares. 1 other person at Claritev bought some too, in the same month.
Insider buying
Bought outside the usual windowTraded Nov 10 · filed 2 days later
A major shareholder of Claritev paid $1.71M out of pocket for Claritev shares. 1 other person at Claritev bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Travis Dalton, Pres., CEO & Executive Chair's past purchases, 90 days after disclosure: 3 buys, median +89.3 pts vs S&P 500, beat it 2 of 3 times. Past results, not a forecast.